Navigation Links
Blood cell researcher wins science academy's 2013 Gottschalk Medal
Date:1/15/2013

Walter and Eliza Hall Institute researcher Dr Benjamin Kile has been awarded the Australian Academy of Science's 2013 Gottschalk Medal for a series of major discoveries that have shed new light on blood cell formation and function.

The Gottschalk Medal, named in honour of biochemist Dr Alfred Gottschalk, recognises outstanding research in the medical sciences by researchers less than 40 years of age.

Dr Kile, a laboratory head in the institute's Cancer and Haematology division, said he was honoured to be awarded the Gottschalk Medal. "I love what I do, and it has been a privilege to be able to pursue a career in medical research in Australia," Dr Kile said. "This award is recognition for work that has involved literally dozens of colleagues and collaborators, here at the Walter and Eliza Hall Institute, nationally and internationally".

Dr Kile's work has centred on understanding the genes that are essential for the formation and function of blood cells and blood stem cells.

One of Dr Kile's best-known discoveries was that platelets, tiny cells essential for blood clotting, are born with a short, predetermined lifespan and when their biological clock runs out, they are programmed to commit suicide. This finding solved a 100-year-old mystery about platelet biology and has implications for blood transfusions and cancer treatment.

"Our research team showed platelets have an internal programmed cell death pathway that tells them when to die, rather than dying as a result of external factors," Dr Kile said. "This raises the prospect of extending the life span of blood bank platelets by inhibiting the cell death pathway; increasing the availability of this life-saving product for cancer patients and others in danger of serious bleeding," Dr Kile said. "It also has implications for understanding conditions where platelets cause unwanted blood clots, such as heart disease and stroke, which are two of the biggest killers in Australia today."

In 2008 Dr Kile and his colleagues also made the discovery that a gene called ERG, which is involved in prostate cancer and leukaemia, is a master regulator of blood stem cell function. Identifying the targets of ERG may ultimately lead to new cancer therapies.

"Everybody knew the Erg gene was highly oncogenic (cancer-causing) it is one of the most commonly rearranged genes in human cancer but we didn't know what its day job was," Dr Kile said. "Our research showed that Erg is essential for maintaining and regulating blood stem cells, which underpin the body's blood and immune systems. This immediately suggested an explanation for Erg's profound oncogenicity; cancers acquire a lot of characteristics of stem cells, so the fact it is switched on in tumours suddenly made sense."

Institute director Professor Doug Hilton said Dr Kile's discoveries, while having basic biological significance, have also directly informed clinical practice, and have the potential to lead to new therapeutics.

"Ben has shown a willingness to pursue the translational implications of his work to a remarkable degree," Professor Hilton said. "He has already cemented his international standing as one of the brightest young stars of blood cell research, and his career trajectory remains resolutely upwards."


'/>"/>
Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related medicine news :

1. Infection Might Raise Blood Clot Risk for Older Adults: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Common Blood Pressure Drug Safe for Heart Failure: Study
4. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
5. High Blood Pressure May Be Especially Lethal for Blacks
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Researchers Develop Blood Test for Depression
8. Naturopathic care can improve blood sugar, mood in diabetes
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Exercise May Help Patients With High Blood Pressure Live Longer
11. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood cell researcher wins science academy's 2013 Gottschalk Medal
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... Metabolic ... supplement GlycoLoad at this week’s 2016 Europa Games Get Fit and Sports Expo ... consumers alike, the Europa Orlando Expo coming up April 29-30, was selected as the ...
(Date:4/28/2016)... ... ... The Aging in Motion Coalition (AIM) has announced the Centers for ... recognition for separate reporting and data collection. The code, M62.84, will be available for ... a combination of low muscle mass and weakness in older adults that causes functional ...
(Date:4/28/2016)... ... April 28, 2016 , ... Prescription ... co-operative bankruptcy to receive their prescription medications through America’s fastest-growing pharmacy program. ... medications from over 180 American pharmaceutical companies for $35 per month, per ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... latest offering, the Protocol Calendar Exchange , is officially open to all ... protocol calendars available for sites to download into their clinical trial management system ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Medical Officer at the Steadman Philippon Research Institute in Vail, Colorado, attended the ... raise awareness about the debilitating and costly musculoskeletal disorders that are affecting millions ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... insights on healthcare, announced today that it has been ... Cool Vendor in Life Sciences, 2016, ... 2016.  The report focuses on life-science- oriented analytics, algorithms ... from patients and doctors, confirm medication ingestion, and analyze ...
(Date:4/28/2016)... FREMONT, Calif. , April 28, 2016 ... Enterprise Validation Lifecycle Management Solutions (VLMS) today ... products and services for sufferers of chronic ... management System to manage their corporate validation ... been seeking a software solution to manage ...
(Date:4/27/2016)... 27 Avril 2016   ... de +5% sur le trimestre, soutenu par une ... Croissance de +16% des ventes aux ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), ... annonce aujourd,hui son chiffre d,affaires pour le premier ...
Breaking Medicine Technology: